Ameriprise Financial Inc Vyne Therapeutics Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.37 - $0.71 $1,048 - $2,012	-2,834 Reduced 13.3%	18,479 $7,000
Q1 2022 May 16, 2022	SELL	$0.5 - $1.15 $179 - $412	-359 Reduced 1.66%	21,313 $14,000
Q4 2021 Feb 14, 2022	SELL	$0.91 - $1.5 $9,524 - $15,699	-10,466 Reduced 32.57%	21,672 $22,000
Q3 2021 Nov 15, 2021	BUY	$1.39 - $3.47 $34 - $86	25 Added 0.08%	32,138 $45,000
Q2 2021 Aug 16, 2021	BUY	$3.24 - $6.92 $113 - $242	35 Added 0.11%	32,113 $113,000
Q1 2021 May 17, 2021	BUY	$6.34 - $12.68 $203,374 - $406,749	32,078 New	32,078 $220,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $176M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.